Source Natural Foods & Herbal Supplements Ltd
Incorporated in 1998, Source Natural Foods
and Herbal Supplements Ltd provides Ayurveda, Health & Dietary Supplements and Food Products[1]
- Market Cap ₹ 119 Cr.
- Current Price ₹ 185
- High / Low ₹ 199 / 74.5
- Stock P/E 67.2
- Book Value ₹ 30.2
- Dividend Yield 0.00 %
- ROCE 18.4 %
- ROE 9.52 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company is expected to give good quarter
- Company's working capital requirements have reduced from 157 days to 115 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 12.7% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
3.76 | 4.54 | 6.54 | 10.93 | 15.94 | 10.84 | 12.81 | 13.59 | 24.88 | 21.53 | 19.79 | 27.30 | |
3.16 | 4.12 | 5.83 | 9.97 | 14.12 | 9.43 | 11.22 | 11.20 | 20.71 | 17.68 | 16.24 | 22.85 | |
Operating Profit | 0.60 | 0.42 | 0.71 | 0.96 | 1.82 | 1.41 | 1.59 | 2.39 | 4.17 | 3.85 | 3.55 | 4.45 |
OPM % | 15.96% | 9.25% | 10.86% | 8.78% | 11.42% | 13.01% | 12.41% | 17.59% | 16.76% | 17.88% | 17.94% | 16.30% |
0.00 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.02 | 0.33 | 0.49 | 0.01 | -0.04 | |
Interest | 0.00 | 0.00 | 0.01 | 0.01 | 0.07 | 0.24 | 0.20 | 0.23 | 0.10 | 0.24 | 0.39 | 0.19 |
Depreciation | 0.25 | 0.26 | 0.54 | 0.49 | 0.35 | 0.35 | 0.34 | 0.34 | 0.37 | 0.42 | 0.43 | 1.04 |
Profit before tax | 0.35 | 0.17 | 0.16 | 0.47 | 1.41 | 0.83 | 1.05 | 1.84 | 4.03 | 3.68 | 2.74 | 3.18 |
Tax % | 0.00% | 0.00% | 0.00% | 10.64% | 0.71% | 3.61% | 2.86% | 11.41% | 16.38% | 33.97% | 22.63% | 45.28% |
0.35 | 0.17 | 0.16 | 0.43 | 1.40 | 0.80 | 1.03 | 1.64 | 3.37 | 2.43 | 2.12 | 1.74 | |
EPS in Rs | 0.78 | 0.33 | 0.26 | 0.67 | 2.17 | 1.24 | 1.60 | 2.55 | 5.24 | 3.78 | 3.29 | 2.70 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 62.52% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 20% |
5 Years: | 16% |
3 Years: | 3% |
TTM: | 38% |
Compounded Profit Growth | |
---|---|
10 Years: | 26% |
5 Years: | 11% |
3 Years: | -19% |
TTM: | -17% |
Stock Price CAGR | |
---|---|
10 Years: | 35% |
5 Years: | 19% |
3 Years: | 7% |
1 Year: | 102% |
Return on Equity | |
---|---|
10 Years: | 15% |
5 Years: | 16% |
3 Years: | 13% |
Last Year: | 10% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 4.50 | 5.20 | 6.10 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 |
Reserves | -2.09 | -1.73 | -1.39 | -0.88 | 0.53 | 1.33 | 2.36 | 3.35 | 6.73 | 9.16 | 11.28 | 13.02 |
2.22 | 0.00 | 0.09 | 0.08 | 1.91 | 1.77 | 0.16 | 1.12 | 0.93 | 0.04 | 0.02 | 0.00 | |
0.33 | 2.03 | 1.20 | 0.98 | 2.63 | 1.56 | 1.84 | 2.23 | 3.13 | 3.69 | 3.96 | 4.19 | |
Total Liabilities | 4.96 | 5.50 | 6.00 | 6.62 | 11.51 | 11.10 | 10.80 | 13.14 | 17.23 | 19.33 | 21.70 | 23.65 |
3.48 | 3.87 | 3.66 | 3.31 | 3.53 | 3.58 | 3.57 | 3.31 | 3.88 | 5.00 | 4.58 | 5.52 | |
CWIP | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.34 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
1.47 | 1.63 | 2.34 | 3.31 | 7.98 | 7.52 | 7.23 | 9.83 | 13.01 | 14.33 | 17.12 | 18.13 | |
Total Assets | 4.96 | 5.50 | 6.00 | 6.62 | 11.51 | 11.10 | 10.80 | 13.14 | 17.23 | 19.33 | 21.70 | 23.65 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.49 | 0.00 | 0.38 | 0.38 | -0.69 | 0.11 | 2.64 | -0.36 | 4.46 | -0.70 | 2.51 | 2.37 | |
-0.30 | 0.00 | -0.40 | -0.16 | -1.95 | 0.14 | -0.31 | -0.71 | -2.09 | 0.07 | 0.06 | 0.62 | |
0.19 | 0.00 | 0.11 | 0.01 | 2.06 | -0.42 | -1.60 | 0.32 | 0.32 | -1.20 | -0.53 | -0.04 | |
Net Cash Flow | 0.38 | 0.00 | 0.08 | 0.23 | -0.58 | -0.18 | 0.74 | -0.74 | 2.69 | -1.83 | 2.04 | 2.95 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 11.65 | 28.14 | 12.84 | 27.72 | 100.52 | 139.06 | 94.88 | 182.37 | 87.88 | 131.22 | 136.67 | 100.41 |
Inventory Days | 142.99 | 143.08 | 218.30 | 143.24 | 115.92 | 202.88 | 149.49 | 92.38 | 64.09 | 106.83 | 141.55 | 93.59 |
Days Payable | 101.60 | 90.52 | 108.28 | 81.70 | 84.18 | 36.13 | 46.29 | 58.58 | 22.10 | 57.67 | 78.93 | 60.94 |
Cash Conversion Cycle | 53.04 | 80.70 | 122.86 | 89.26 | 132.26 | 305.81 | 198.08 | 216.16 | 129.86 | 180.37 | 199.29 | 133.06 |
Working Capital Days | 46.60 | 58.69 | 58.60 | 53.76 | 111.74 | 178.80 | 114.54 | 183.17 | 82.01 | 163.43 | 193.47 | 114.71 |
ROCE % | 8.28% | 4.20% | 4.11% | 9.20% | 20.39% | 11.62% | 13.51% | 20.84% | 33.11% | 26.36% | 18.75% |
Documents
Announcements
- Closure of Trading Window 28 Jun
- Board Meeting Outcome for Outcome Of The Board Meeting Held On 26.06.2024 26 Jun
- Board Meeting Intimation for Please Take Notice That The Meeting Of The Board Of The Company Will Be Held On Wednesday, The 26Th June, 2024 18 Jun
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
25 May - Reg 47 of SEBI (LODR) Regulations, 2015 please find attached herewith a copy of the newspaper publication "Extract of Standalone Audited Financial Results" for the …
-
Announcement under Regulation 30 (LODR)-Change in Management
24 May - In accordance with the provision of Sec 148(3) of the Companies Act, 2013 read with Rule 6(2)of the Companies (Cost Records and Audit) Rules, 2014 …
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Product Profile:
a) Beverages:[1]
Ojasvita - Chocolate, Malt, Strawberry, Mango, Golden Latte, etc.
b) Supplements:[2]
Turmeric Plus, Amla, Yastimadhu, Triphala, Nishamlaki, Arjuna
c) Arkas:[3]
Shakti Drops, Tulsi Araka, Ajamoda Arka
d) Single Herbs:[4]
Shakhpushpi, Shatavari, Tulsi, Neem, Brahmi, Ashwagandha, Amrut, Kalamegh, Haritaki
e) Churnas:[5]
Sitophaladi, Hingvastaka, Triphala